COPD Study

The purpose of the study is to learn more about how safe and effective a new drug (study drug) is in treating worsening of COPD symptoms, and to better understand the disease and associated health problems.

The study drug may decrease inflammation in the lungs of people with COPD, which could reduce episodes of COPD symptoms worsening (called exacerbations or flare-ups) and improve health-related quality of life.

All patients will continue to take their regular COPD medication throughout the study. You will be assigned to add either the study drug or a “placebo”.

The study will be administered as tablets for 24 weeks. Over the course of the study, you will complete at least 9 visits to the research site.